LOS
ANGELES, July 30, 2024 /PRNewswire/
-- Agilisium, a pioneering leader in Data Analytics, Cloud,
and Life Science solutions, today announced that it has won the
coveted AWS Life Sciences Competency status; placing the brand
among an exclusive group of 28 Consulting Partners out of 8,300+
AWS Partners globally. This remarkable achievement demonstrates the
company's proven expertise in delivering transformative cloud
solutions to pharmaceutical companies, seeking to expedite drug
discovery, strengthen clinical trials, and develop novel
genetic-based treatments.
Agilisium is an AWS Life Sciences
Competency Partner with 20+ GenAI-powered Data Analytics Solutions
for Pharma Business
Agilisium has developed over 20 GenAI-powered data analytics
solutions exemplifying the company's innovative approach, enabling
pharma organizations to unlock deeper insights, and accelerate
research and development cycles; thereby bringing life-saving
treatments to patients more efficiently. Furthermore, Agilisium's
solutions and accelerators can be accessed through the AWS
marketplace.
Commenting on the achievement, Mr. Raj Babu, Founder and CEO of
Agilisium said, "Earning the AWS Life Sciences Competency status is
a significant milestone for Agilisium. This achievement reflects
our team's unwavering dedication to understanding the complex
challenges in the pharma industry and developing solutions that
effectively address them. By harnessing the power of our GenAI
solutions, we are confident that we can usher in a new era of
data-driven discovery and innovation in life sciences.
Additionally, this recognition would enable our clients to
transform data into meaningful insights, ultimately delivering
life-changing therapies to patients faster, globally."
As one of the few AWS-certified Data Analytics partners with
specialized expertise in the pharmaceutical industry, Agilisium is
uniquely positioned to offer a wide range of AWS services tailored
for the Life Sciences industry. This includes generative AI
solutions, advanced analytics, data lakes, and machine learning,
among several others. The company also offers AWS' MAP (Migration
Acceleration Program) funding program and No-Cost Assessment
program for its clients which significantly helps clients to
accelerate faster Cloud Transformation journeys.
About Agilisium - Agilisium is one of the premier Life
Sciences partners for digital innovations. The company delivers
cutting-edge solutions that drive impactful change by combining our
strong domain expertise with Data, Cloud, GenAI, and Advanced
Analytics. Agilisium collaborates with leading pharma and biotech
companies to provide data-driven insights and innovative solutions
across the value chain, helping accelerate drug discovery, optimize
patient care, achieve commercial success, streamline product
delivery, and foster collaboration. Learn more at
www.Agilisium.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/agilisium-achieves-aws-life-sciences-competency-status-302210118.html
SOURCE Agilisium Consulting